Oxford Biomedica Plc (OXBL)

0.000p
   
  • Closing Price Chg:
    -20.00p
  • 52 Week High: 680.00
  • 52 Week Low: 235.50
  • Currency: UK Pounds
  • Volume: 0

Financial Analysis

Select chart: EPS | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-25 Interim 73.22 (26.03) (25.35)¢ n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 87.73 (6.57) (7.81)p n/a n/a n/a n/a 0.0%
31-Dec-21 142.80 19.88 22.77p 53.9 n/a n/a n/a 0.0%
31-Dec-22 139.99 (45.98) (41.29)p n/a n/a n/a n/a 0.0%
31-Dec-23 89.54 (188.53) (163.11)p n/a n/a n/a n/a 0.0%
31-Dec-24 128.80 (47.26) (41.75)p n/a n/a n/a n/a 0.0%

Forecasts

Forecasts data is not available for this company.

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 53.93 n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

OXBL Market Data

Currency UK Pounds
Share Price 660.00p
Closing Price Change -20.00p
% Change 0.00 %
52 Week High 680.00
52 Week Low 235.50
Volume 0

Trades for 06-Nov-2025

Time Volume / Share Price
11:39 51 @ 657.00p
11:17 124 @ 657.00p
11:17 162 @ 657.00p
11:17 312 @ 657.00p
11:17 282 @ 657.00p

OXBL Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page